Replies to post #137202 on NanoViricides Inc. (NNVC)

[arvitar]

11/14/2017 "...available funds are insufficient...
for the Company’s projected work"

p.10 https://ih.advfn.com/p.php?pid=nmona&article=76095857

"Management believes that the Company’s existing cash resources are sufficient for its operations at the current rate of expenditures to continue through November 2018. However, management believes that the available funds are insufficient for the Company’s projected work, which is beyond normal pre-clinical development operations, leading towards an Investigational New Drug Application (IND) filing with the U.S. Food and Drug Administration (FDA), to continue through November 2018. "

[Ubertino]

I expect further developments to be forthcoming, say at 7AM tomorrow, perhaps, in re:


"The Company will conduct additional studies in order to finalize the candidates for clinical drug development, and to obtain IND-enabling pre-clinical data, under the extension. The final candidate is expected to undergo toxicology and safety studies leading to IND submission to the FDA for the treatment of shingles in humans."

Just a hunch.

smiling out loud

[Farid]

What happened to the oral herpicide cream? They had that in the works since it was topical. 5 billion+ market. Why don’t we hear about these things!!?